Two Sigma Investments, LP Vanda Pharmaceuticals Inc. Transaction History
Two Sigma Investments, LP
- $50.6 Billion
- Q2 2025
A detailed history of Two Sigma Investments, LP transactions in Vanda Pharmaceuticals Inc. stock. As of the latest transaction made, Two Sigma Investments, LP holds 526,866 shares of VNDA stock, worth $2.27 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
526,866
Previous 175,632
199.98%
Holding current value
$2.27 Million
Previous $806,000
208.44%
% of portfolio
0.0%
Previous 0.0%
Shares
32 transactions
Others Institutions Holding VNDA
# of Institutions
152Shares Held
45.1MCall Options Held
33.3KPut Options Held
1M-
Black Rock Inc. New York, NY8.14MShares$35.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.57MShares$15.4 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny3.45MShares$14.9 Million0.02% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny3.12MShares$13.4 Million0.01% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.59MShares$11.1 Million0.0% of portfolio
About Vanda Pharmaceuticals Inc.
- Ticker VNDA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,561,500
- Market Cap $244M
- Description
- Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...